Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
Top Cited Papers
Open Access
- 30 January 2012
- journal article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 6 (1) , 10-20
Abstract
De Silva A, et al. Gut Liver. 2012 Jan;6(1):10-20. http://dx.doi.org/10.5009/gnl.2012.6.1.10Keywords
This publication has 94 references indexed in Scilit:
- Recent advances in understanding leptin signaling and leptin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)Diabetic Medicine, 2009
- GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-CellDiabetes, 2009
- Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin SecretionDiabetes, 2008
- PYY(3–36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of ratsPeptides, 2008
- Eating for pleasure or caloriesCurrent Opinion in Pharmacology, 2007
- Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humansNeuroImage, 2007
- The neurocognitive bases of human multimodal food perception: ConsciousnessBrain Research Reviews, 2007
- Small-molecule agonists for the glucagon-like peptide 1 receptorProceedings of the National Academy of Sciences, 2007
- A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db / db miceProceedings of the National Academy of Sciences, 2007